Tin tức & Cập nhật
Xem bài viết Bệnh nhiễm khuẩn
Xem
Chỉ hiển thị Multimedia

Nirmatrelvir-ritonavir bests molnupiravir in COVID-19 patients with advanced kidney disease
18 Jul 2024
bởiAudrey Abella
In a retrospective observational study, nirmatrelvir-ritonavir trumps molnupiravir in reducing the risk of all-cause mortality at 90 days and hospitalization in COVID-19 patients with advanced kidney disease (chronic kidney disease [CKD] stage 4, ie, eGFR <30 mL/min/1.73 m2).
18 Jul 2024

Glecaprevir/pibrentasvir shows favourable efficacy signals for paediatric HCV
10 Jul 2024
bởiAudrey Abella
Findings from the ongoing POLAC project demonstrate that treatment with the pangenotypic regimen comprising glecaprevir/pibrentasvir (GLE/PIB) for 8 weeks is highly effective against chronic hepatitis C virus (HCV) infection in children and adolescents. This regimen also showed a good safety profile.
10 Jul 2024






